Bioceres Crop Solutions
BIOX
27 hedge funds and large institutions have $85M invested in Bioceres Crop Solutions in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
1,026% more call options, than puts
Call options by funds: $3.56M | Put options by funds: $316K
400% more capital invested
Capital invested by funds: $17M → $85M (+$68M)
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
23% more funds holding
Funds holding: 22 → 27 (+5)
10.41% more ownership
Funds ownership: 3.05% → 13.46% (+10%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Solel Partners
Boston,
Massachusetts
|
+$60.8M |
| 2 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$1.65M |
| 3 |
State Street
Boston,
Massachusetts
|
+$923K |
| 4 |
RA
Royce & Associates
New York
|
+$902K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$756K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
Friess Associates
Greenville,
Delaware
|
-$644K |
| 2 |
ADMI
Albert D. Mason Inc
Boston,
Massachusetts
|
-$265K |
| 3 |
JP Morgan Chase
New York
|
-$60.5K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$55.9K |
| 5 |
Morgan Stanley
New York
|
-$31.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $10K | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $8K | +$7.19K | +542 | +54,200% |
|
28
Rockefeller Capital Management
New York
| $6K | – | – | – |
|
29
Simplex Trading
Chicago,
Illinois
| – | -$2.63K | -198 | Closed |
|
BIOX Hedge Fund Activity: Q2 2022 in Review
27 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Bioceres Crop Solutions (BIOX) for Q2 2022, worth a combined $85M — up 400% from $17M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new BIOX positions and 2 closed out — a net gain of 5 holders — while 8 added to existing stakes and 6 trimmed.
The largest buyer was Solel Partners, opening a new position worth an estimated $60.8M. The largest seller was Friess Associates, cutting an estimated $644K.
- 27 institutional investors held Bioceres Crop Solutions (BIOX) as of Q2 2022, up from 22 in Q1 2022.
- Funds reported $85M of Bioceres Crop Solutions stock for Q2 2022, up 400% quarter-over-quarter.
- 7 funds opened new Bioceres Crop Solutions positions in Q2 2022 and 2 closed out, a net change of +5 holders.
- The largest Bioceres Crop Solutions buyer in Q2 2022 was Solel Partners, an estimated $60.8M added.
- The largest Bioceres Crop Solutions seller in Q2 2022 was Friess Associates, an estimated $644K sold.
Based on aggregated 13F filings for Q2 2022.